Simply mixing with poly(ethylene glycol) enhances the fraction of the active chemical form of antitumor drugs of camptothecin family

Journal of Controlled Release

Volumn 169, Issue 3, 2013, Pages 329-335

  Ci, Tianyuan ^a   Li, Ting ^a   Chang, Guangtao ^a   Yu, Lin ^a   Ding, Jiandong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

10 Hydrocamptothecin (HCPT); Anticancer; Camptothecin (CPT); Drug material interaction; Poly(ethylene glycol) (PEG); Topotecan (TPT)

Indexed keywords

BODY FLUIDS; CARBOXYLATION; ESTERS; ETHYLENE GLYCOL; MIXING; POLYOLS;

10-HYDROCAMPTOTHECIN (HCPT); ANTICANCER; CAMPTOTHECIN (CPT); DRUG MATERIALS; TOPOTECAN;

POLYETHYLENE GLYCOLS;

CAMPTOTHECIN; CARBOXYLIC ACID; LACTONE; MACROGOL; TOPOTECAN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG SOLUTION; HUMAN; HUMAN CELL; HYDROLYSIS; PRIORITY JOURNAL; SOLID TUMOR;

EID: 84885182945     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.12.004     Document Type: Article

References (49)

1. G. Pasut, F.M. Veronese, State of the art in PEGylation: the great versatility achieved after forty years of research, J. Control. Release 161 (2012) 461-472.
2. N. Bertrand, M.A. Gauthier, C. Bouvet, P. Moreau, A. Petitjean, J.C. Leroux, J. Leblond, New pharmaceutical applications for macromolecular binders, J. Control. Release 155 (2011) 200-210.
3. R.M. Dannenfelser, H. He, Y. Joshi, S. Bateman, A.T.M. Serajuddin, Development of clinical dosage forms for a poorly water soluble drug I: application of polyethylene glycol-polysorbate 80 solid dispersion carrier system, J. Pharm. Sci. 93 (2004) 1165-1175. (Pubitemid 38529690)
4. O. Mert, S.K. Lai, L. Ensign, M. Yang, Y.Y. Wang, J. Wood, J. Hanes, A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles, J. Control. Release 157 (2012) 455-460.
5. B. Jeong, Y.H. Bae, D.S. Lee, S.W. Kim, Biodegradable block copolymers as injectable drug-delivery systems, Nature 388 (1997) 860-862. (Pubitemid 27377054)
6. J.S. Lee, J. Feijen, Polymersomes for drug delivery: design, formation and characterization, J. Control. Release 161 (2012) 473-483.
7. M. Talelli, K. Morita, C.J.F. Rijcken, R.W.M. Aben, T. Lammers, H.W. Scheeren, C.F. van Nostrum, G. Storm, W.E. Hennink, Synthesis and characterization of biodegradable and thermosensitive polymeric micelles with covalently bound doxorubicin-glucuronide prodrug via click chemistry, Bioconjug. Chem. 22 (2011) 2519-2530.
8. W. Wang, H.L. Sun, F.H. Meng, S.B. Ma, H.Y. Liu, Z.Y. Zhong, Precise control of intracellular drug release and anti-tumor activity of biodegradable micellar drugs via reduction-sensitive shell-shedding, Soft Matter 8 (2012) 3949-3956.
9. G.H. Gao, J.W. Lee, M.K. Nguyen, G.H. Im, J. Yang, H. Heo, P. Jeon, T.G. Park, J.H. Lee, D.S. Lee, pH-responsive polymeric micelle based on PEG-poly(beta-amino ester)/(amido amine) as intelligent vehicle for magnetic resonance imaging in detection of cerebral ischemic area, J. Control. Release 155 (2011) 11-17.
10. J.K. Kim, Y.W. Won, K.S. Lim, Y.H. Kim, Low-molecular-weight methylcellulose-based thermo-reversible gel/pluronic micelle combination system for local and sustained docetaxel delivery, Pharm. Res. 29 (2012) 525-534.
11. Y. Zhang, W. Zhu, B.B. Wang, J.D. Ding, Anovel microgel and associated post-fabrication encapsulation technique of proteins, J. Control. Release 105 (2005) 260-268. (Pubitemid 40941991)
12. L. Yu, J.D. Ding, Injectable hydrogels as unique biomedical materials, Chem. Soc. Rev. 37 (2008) 1473-1481.
13. H.Y. Yoon, G. Saravanakumar, R. Heo, S.H. Choi, I.C. Song, M.H. Han, K. Kim, J.H. Park, K. Choi, I.C. Kwon, K. Park, Hydrotropic magnetic micelles for combined magnetic resonance imaging and cancer therapy, J. Control. Release 160 (2012) 692-698.
14. Z. Zhang, J. Ni, L. Chen, L. Yu, J.W. Xu, J.D. Ding, Biodegradable and thermoreversible PCLA-PEG-PCLA hydrogel as a barrier for prevention of post-operative adhesion, Biomaterials 32 (2011) 4725-4736.
15. R. Peng, X. Yao, B. Cao, J. Tang, J.D. Ding, The effect of culture conditions on the adipogenic and osteogenic inductionsofmesenchymal stem cellson micropatterned surfaces, Biomaterials 33 (2012) 6008-6019.
16. M.E. Wall, M.C. Wani, C.E. Cook, K.H. Palmer, A.T. McPhail, G.A. Sim, Plant antitumor agents. I. Isolation and structure of camptothecin a novel alkaloidal leukemia and tumor inhibitor from camptotheca acuminata, J. Am. Chem. Soc. 88 (1966) 3888-3890.
17. Y. Pommier, Topoisomerase I inhibitors: camptothecins and beyond, Nat. Rev. Cancer 6 (2006) 789-802. (Pubitemid 44450467)
18. V.J. Venditto, E.E. Simanek, Cancer therapies utilizing the camptothecins: a review of the in vivo literature, Mol. Pharm. 7 (2010) 307-349.
19. D.C. Drummond, C.O. Noble, Z. Guo, M.E. Hayes, C. Connolly-Ingram, B.S. Gabriel, B. Hann, B. Liu, J.W. Park, K. Hong, C.C. Benz, J.D. Marks, D.B. Kirpotin, Development of a highly stable and targetable nanoliposomal formulation of topotecan, J. Control. Release 141 (2010) 13-21.
20. J.B. Wolinsky, R. Liu, J. Walpole, L.R. Chirieac, Y.L. Colson, M.W. Grinstaff, Prevention of in vivo lung tumor growth by prolonged local delivery of hydroxycamptothecin using poly(ester-carbonate)-collagen composites, J. Control. Release 144 (2010) 280-287.
21. M.H. Hong, S.J. Zhu, Y.Y. Jiang, G.T. Tang, C. Sun, C. Fang, B. Shi, Y.Y. Pei, Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles, J. Control. Release 141 (2010) 22-29.
22. K.H. Min, J.-H. Kim, S.M. Bae, H. Shin, M.S. Kim, S. Park, H. Lee, R.-W. Park, I.-S. Kim, K. Kim, I.C. Kwon, S.Y. Jeong, D.S. Lee, Tumoral acidic pH-responsive MPEG-poly(β-amino ester) polymeric micelles for cancer targeting therapy, J. Control. Release 144 (2010) 259-266.
23. S. Svenson, M. Wolfgang, J. Hwang, J. Ryan, S. Eliasof, Preclinicalto clinical development of the novel camptothecin nanopharmaceutical CRLX101, J. Control. Release 153 (2011) 49-55.
24. M. Verreault, D. Strutt, D. Masin, M. Anantha, D. Waterhouse, D.T. Yapp, M.B. Bally, Irinophore C (TM), a lipid-based nanoparticulate formulation of irinotecan, is more effective than free irinotecan when used to treat an orthotopic glioblastoma model, J. Control. Release 158 (2012) 34-43.
25. D. Zucker, A.V. Andriyanov, A. Steiner, U. Raviv, Y. Barenholz, Characterization of PEGylated nanoliposomes co-remotely loaded with topotecan and vincristine: relating structure and pharmacokinetics to therapeutic efficacy, J. Control. Release 160 (2012) 281-289.
26. Y.H. Hsiang, L.F. Liu, M.E. Wall, M.C. Wani, A.W. Nicholas, G. Manikumar, S. Kirschenbaum, R. Silber, M. Potmesil, DNA topoisomerase I-mediated DNA cleavage and cyto-toxicity of camptothecin analogs, Cancer Res. 49 (1989) 4385-4389. (Pubitemid 19208330)
27. M. Potmesil, Camptothecins - from bench research to hospital wards, Cancer Res. 54 (1994) 1431-1439. (Pubitemid 24106402)
28. G.L. Beretta, F. Zunino, Relevance of extracellular and intracellular interactions of camptothecins as determinants of antitumor activity, Biochem. Pharmacol. 74 (2007) 1437-1444. (Pubitemid 47575490)
29. T.G. Burke, Z.H. Mi, The structural basis of Camptothecin interactions with human serum-albumin - impact on drug stability, J. Med. Chem. 37 (1994) 40-46. (Pubitemid 24058811)
30. R. Barreiro-Iglesias, L. Bromberg, M. Temchenko, T.A. Hatton, A. Concheiro, C. Alvarez-Lorenzo, Solubilization and stabilization of camptothecin in micellar solutions of pluronic-g-poly(acrylic acid) copolymers, J. Control. Release 97 (2004) 537-549. (Pubitemid 38802955)
31. K.H. Min, K. Park, Y.S. Kim, S.M. Bae, S. Lee, H.G. Jo, R.W. Park, I.S. Kim, S.Y. Jeong, K. Kim, I.C. Kwon, Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy, J. Control. Release 127 (2008) 208-218.
32. M. Watanabe, K. Kawano, K. Toma, Y. Hattori, Y. Maitani, In vivo antitumor activity of camptothecin incorporated in liposomes formulated with an artificial lipid and human serum albumin, J. Control. Release 127 (2008) 231-238.
33. Y.Q. Tang, P.R. Czuczman, S.T. Chung, A.L. Lewis, Preservation of the active lactone form of irinotecan using drug eluting beads for the treatment of colorectal cancer metastases, J. Control. Release 127 (2008) 70-78.
34. J. Liu, Z.Z. Jiang, S.M. Zhang, W.M. Saltzman, Poly(omega- pentadecalactone-co-butylene-co-succinate) nanoparticles as biodegradable carriers for camptothecin delivery, Biomaterials 30 (2009) 5707-5719.
35. W.L. Zhang, J. Huang, N.Q. Fan, J.H. Yu, Y.B. Liu, S.Y. Liu, D.X. Wang, Y.P. Li, Nanomicelle with long-term circulation and enhanced stability of camptothecin based on MPEGylated alpha, beta-poly (l-aspartic acid)-camptothecin conjugate, Colloid Surf B Biointerfaces 81 (2010) 297-303.
36. G.T. Chang, T.Y. Ci, L. Yu, J.D. Ding, Enhancement of the fraction of the active form of an antitumor drug topotecan via an injectable hydrogel, J. Control. Release 156 (2011) 21-27.
37. Q. Guo, P. Luo, Y. Luo, F. Du, W. Lu, S. Liu, J. Huang, J. Yu, Fabrication of biodegradable micelles with sheddable poly(ethylene glycol) shells as the carrier of 7-ethyl-10-hydroxy-camptothecin, Colloid Surf B Biointerfaces 100 (2012) 138-145.
38. a of the proton release complex in the photocycle of retinal proteins, J. Phys. Chem. B 113 (2009) 4482-4491.
39. Y.Z. Wang, D.W. Ma, Y.C. Zhao, M. Ming, J. Wu, J.D. Ding, Light-driven proton pumps of archaerhodopsin and bacteriorhodopsin and polymer-matrix composite materials of those functional proteins, Acta Polym. Sin. (2012) 698-713.
40. Z.H. Mi, T.G. Burke, Differential interactions of camptothecin lactone and carboxylate forms with human blood components, Biochemistry 33 (1994) 10325-10336. (Pubitemid 24281798)
41. G. Akerlof, Dielectric constants of some organic solvent-water mixtures at various temperatures, J. Am. Chem. Soc. 54 (1932) 4125-4139.
42. A. Hirano, K. Shiraki, T. Arakawa, Polyethylene glycol behaves like weak organic solvent, Biopolymers 97 (2012) 117-122.
43. J. Fassberg, V.J. Stella, A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues, J. Pharm. Sci. 81 (1992) 676-684. (Pubitemid 23006796)
44. E. Bosch, C. Rafols, M. Roses, Variation of acidity constants and pH values of some organic-acids in water-2-propanol mixtures with solvent composition - effect of preferential solvation, Anal. Chim. Acta 302 (1995) 109-119.
45. V.V. Aleksandrov, O.N. Tychina, T.A. Berezhnaya, N.O. Mchedlov-Petrossyan, Protonic acidity scales in the system n-butyl alcohol-water, J. Mol. Liq. 100 (2002) 255-264. (Pubitemid 34950695)
46. R.G. Bates, M. Paabo, R.A. Robinson, Interpretation of pH measurements in alcohol-water solvents, J. Phys. Chem. 67 (1963) 1833-1838.
47. A. Shenderova, T.G. Burke, S.P. Schwendeman, The acidic microclimate in poly(lactide-co-glycolide) microspheres stabilizes camptothecins, Pharm. Res. 16 (1999) 241-248.
48. E.S. Lee, Z.G. Gao, Y.H. Bae, Recent progress in tumor pH targeting nanotechnology, J. Control. Release 132 (2008) 164-170.
49. G.T. Chang, C. Li, W.Y. Lu, J.D. Ding, N-boc-histidine-capped PLGA-PEG-PLGA as a smart polymer for drug delivery sensitive to tumor extracellular pH, Macromol. Biosci. 10 (2010) 1248-1256.